XML 35 R20.htm IDEA: XBRL DOCUMENT
v3.20.4

Stockholders' Equity | 12 Months Ended
--- | ---
Oct. 31, 2020
Stockholders' Equity Note [Abstract] |
Stockholders' Equity |
11 | Stockholders' Equity
Stock Repurchase Program On December 3, 2015, the company's Board authorized the repurchase of 8,000,000 shares of the company's common stock in open-market or in privately negotiated transactions. On December 4, 2018, the company's Board authorized the repurchase of up to an additional 5,000,000 shares of common stock in open-market or in privately negotiated transactions under the authorized stock repurchase program. This authorized stock repurchase program has no expiration date but may be terminated by the Board at any time. No shares were repurchased under the authorized stock repurchase program during fiscal 2020. The company curtailed the repurchase of shares of its common stock during fiscal 2020 as a result of the Venture Products transaction and to enhance its liquidity position in response to COVID-19. During fiscal 2019 and 2018, the company paid $20.0 million and $160.4 million to repurchase an aggregate of 359,758 shares and 2,579,864 shares, respectively, under the authorized stock repurchase program. As a result of the CMW transaction, the company curtailed the repurchase of shares of its common stock under the authorized stock repurchase program during the company's fiscal 2019 second, third, and fourth quarters. As of October 31, 2020, 7,042,256 shares remained authorized by the company's Board for repurchase. The authorized stock repurchase program does not include shares of the company's common stock surrendered by employees to satisfy minimum tax withholding obligations upon vesting of certain stock-based compensation awards granted under the company's 2010 plan. Treasury Shares Treasury shares generally consist of shares of the company's common stock repurchased under the company's Board authorized stock repurchase program. The company values treasury shares on an average cost basis. As of October 31, 2020, the company had a total of 20,545,330 treasury shares at an average cost of $1,323.2 million. As of October 31, 2019, the company had a total of 21,385,919 treasury shares at an average cost of $1,374.0 million. Accumulated Other Comprehensive Loss The components of AOCL, net of tax, within the Consolidated Statements of Stockholders' Equity were as follows (in thousands):
As of October 31 |  | 2020 |  | 2019 |  | 2018
Foreign currency translation adjustments |  | $ | 24,508 |  |  | $ | 31,025 |  |  | $ | 29,711 |
Pension and post-retirement benefits |  | 5,106 |  |  | 4,861 |  |  | 561 |
Cash flow derivative instruments |  | 4,648 |  |  | (3,837) |  |  | (6,335) |
Total accumulated other comprehensive loss |  | $ | 34,262 |  |  | $ | 32,049 |  |  | $ | 23,937 |
The components and activity of AOCL, net of tax, were as follows (in thousands):
|  | Foreign Currency Translation Adjustments |  | Pension Benefits |  | Cash Flow Derivative Instruments |  | Total
Balance as of October 31, 2019 |  | $ | 31,025 |  |  | $ | 4,861 |  |  | $ | (3,837) |  |  | $ | 32,049 |
Other comprehensive (income) loss before reclassifications |  | (6,517) |  |  | 245 |  |  | 14,159 |  |  | 7,887 |
Amounts reclassified from AOCL |  | — |  |  | — |  |  | (5,674) |  |  | (5,674) |
Net current period other comprehensive (income) loss |  | (6,517) |  |  | 245 |  |  | 8,485 |  |  | 2,213 |
Balance as of October 31, 2020 |  | $ | 24,508 |  |  | $ | 5,106 |  |  | $ | 4,648 |  |  | $ | 34,262 |
|  | Foreign Currency Translation Adjustments |  | Pension and Post-Retirement Benefits |  | Cash Flow Derivative Instruments |  | Total
Balance as of October 31, 2018 |  | $ | 29,711 |  |  | $ | 561 |  |  | $ | (6,335) |  |  | $ | 23,937 |
Other comprehensive (income) loss before reclassifications |  | 1,314 |  |  | 4,300 |  |  | (4,048) |  |  | 1,566 |
Amounts reclassified from AOCL |  | — |  |  | — |  |  | 6,546 |  |  | 6,546 |
Net current period other comprehensive loss |  | 1,314 |  |  | 4,300 |  |  | 2,498 |  |  | 8,112 |
Balance as of October 31, 2019 |  | $ | 31,025 |  |  | $ | 4,861 |  |  | $ | (3,837) |  |  | $ | 32,049 |
For additional information on the components reclassified from AOCL to the respective line items in net earnings for derivative instruments refer to Note 14, Derivative Instruments and Hedging Activities.

X
- References No definition available. + Details
Name: | us-gaap_StockholdersEquityNoteAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08(e)(1)) -URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.3-04) -URI http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -URI http://asc.fasb.org/topic&trid=2208762 + Details
Name: | us-gaap_StockholdersEquityNoteDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration